Unicredit Bank AG (UC92SC) News

- Current report filing (8-K)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________ FORM 8-K...

AtheroGenics Receives Delisting Notice From NASDAQ Global Market Due to Chapter 11 Filing

ATLANTA, GA -- (Marketwire) -- 10/10/08 -- AtheroGenics, Inc. (NASDAQ: AGIX) today reported that it received notification from the Nasdaq Stock...

- Withdrawal of Registration Statement (RW)

      [AtheroGenics Letterhead] October 10, 2008 VIA FACSIMILE AND EDGAR Securities and Exchange Commission...

Atherogenics Inc - Current report filing (8-K)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________ FORM 8-K...

AtheroGenics Files for Chapter 11 Bankruptcy

ATLANTA, GA -- (Marketwire) -- 10/07/08 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic...

Atherogenics Inc - Current report filing (8-K)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________ FORM 8-K...

Atherogenics Inc - Current report filing (8-K)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________ FORM 8-K...

Atherogenics Inc - Current report filing (8-K)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO...

Atherogenics Inc - Current report filing (8-K)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO...

AtheroGenics Restructures Board of Directors

ATLANTA, GA -- (Marketwire) -- 09/10/08 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic...

BellwetherReport.com Analyst Opinions on SCRX, AGIX, BUCY and ISIL

TORONTO -- (Marketwire) -- 09/02/08 -- BellwetherReport.com is the leading online financial newsletter for investors seeking top independent and...

Atherogenics Inc - Current report filing (8-K)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________ FORM 8-K...

AtheroGenics Seeks to Realign Capital Structure

ATLANTA, GA -- (Marketwire) -- 09/02/08 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic...

Atherogenics Inc - Confidential Treatment Order (CT ORDER)